UY37629A - Análogos de insulina de cadena simple estabilizados por un cuarto puente disulfuro - Google Patents
Análogos de insulina de cadena simple estabilizados por un cuarto puente disulfuroInfo
- Publication number
- UY37629A UY37629A UY0001037629A UY37629A UY37629A UY 37629 A UY37629 A UY 37629A UY 0001037629 A UY0001037629 A UY 0001037629A UY 37629 A UY37629 A UY 37629A UY 37629 A UY37629 A UY 37629A
- Authority
- UY
- Uruguay
- Prior art keywords
- insulin
- chain insulin
- bridge
- disulfured
- polypeptide sequence
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical class N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title abstract 9
- 102000004877 Insulin Human genes 0.000 abstract 5
- 108090001061 Insulin Proteins 0.000 abstract 5
- 229940125396 insulin Drugs 0.000 abstract 3
- 230000004927 fusion Effects 0.000 abstract 1
- 239000004026 insulin derivative Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 230000011664 signaling Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Un análogo de insulina monocatenario comprende: una secuencia polipeptídica de insulina de cadena B conectada a una secuencia polipeptídica de insulina de cadena A por una secuencia polipeptídica de dominio C. El análogo reivindicado mitiga la actividad desfavorable del cuarto puente disulfuro en análogos de insulina de dos cadenas, resultando en una duración de la señalización de la insulina similar a la de la insulina tipo salvaje. El uso del análogo de la presente invención en un dispositivo de administración de insulina (bomba o bolígrafo) o como parte de un proceso de fabricación de fusión de polímero a alta temperatura.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762468037P | 2017-03-07 | 2017-03-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY37629A true UY37629A (es) | 2018-10-31 |
Family
ID=63448061
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY0001037629A UY37629A (es) | 2017-03-07 | 2018-03-07 | Análogos de insulina de cadena simple estabilizados por un cuarto puente disulfuro |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11174303B2 (es) |
| AR (1) | AR111122A1 (es) |
| TW (1) | TW201835099A (es) |
| UY (1) | UY37629A (es) |
| WO (1) | WO2018165290A1 (es) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017112952A1 (en) * | 2015-12-23 | 2017-06-29 | Case Western Reserve University | Encapsulation of ultra-stable insulin analogues with polymer melts |
| DK3551209T3 (da) | 2016-12-09 | 2021-08-23 | Akston Biosciences Corp | Insulin-fc-fusioner og fremgangsmåder til anvendelse |
| LT3892628T (lt) | 2018-06-29 | 2022-12-12 | Akston Biosciences Corporation | Itin ilgai veikiantys insulino-fc sulieti baltymai ir naudojimo būdai |
| US11267862B2 (en) | 2018-06-29 | 2022-03-08 | Akston Biosciences Corporation | Ultra-long acting insulin-Fc fusion proteins and methods of use |
| BR112021005366A2 (pt) * | 2018-09-21 | 2021-06-29 | Case Western Reserve University | análogo de insulina de cadeia simples, uso deste e método para reduzir o açúcar no sangue de um paciente |
| CN113330025A (zh) * | 2018-11-19 | 2021-08-31 | 卡斯西部储备大学 | 具有聚丙氨酸c结构域子区段的单链胰岛素类似物 |
| AU2020279968A1 (en) * | 2019-05-17 | 2021-12-16 | Case Western Reserve University | Variant single-chain insulin analogues |
| JP2022542301A (ja) | 2019-07-31 | 2022-09-30 | イーライ リリー アンド カンパニー | リラキシン類似体およびその使用方法 |
| EP4007594A4 (en) * | 2019-08-02 | 2023-08-09 | Case Western Reserve University | PREMIXED ULTRASTABLE SINGLE-CHAIN INSULIN ANALOGUE FORMULATIONS |
| US11352407B2 (en) | 2019-12-19 | 2022-06-07 | Akston Biosciences Corporation | Ultra-long acting insulin-Fc fusion proteins |
| US11186623B2 (en) | 2019-12-24 | 2021-11-30 | Akston Bioscience Corporation | Ultra-long acting insulin-Fc fusion proteins and methods of use |
| EP4248983A3 (en) | 2020-04-10 | 2024-01-24 | Akston Biosciences Corporation | Antigen specific immunotherapy for covid-19 fusion proteins and methods of use |
| US11192930B2 (en) | 2020-04-10 | 2021-12-07 | Askton Bioscences Corporation | Ultra-long acting insulin-Fc fusion protein and methods of use |
| US11198719B2 (en) | 2020-04-29 | 2021-12-14 | Akston Biosciences Corporation | Ultra-long acting insulin-Fc fusion protein and methods of use |
| EP4255469A1 (en) * | 2020-12-07 | 2023-10-11 | Case Western Reserve University | Acylated single-chain insulin analogues |
| WO2023004406A2 (en) | 2021-07-23 | 2023-01-26 | Akston Biosciences Corporation | Insulin-fc fusion proteins and methods of use to treat cancer |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3538574B2 (ja) | 1999-09-27 | 2004-06-14 | 株式会社リンレイ | 可剥離性被覆組成物 |
| AU2009335715B2 (en) * | 2008-12-19 | 2016-09-15 | Indiana University Research And Technology Corporation | Amide-based insulin prodrugs |
| KR102351111B1 (ko) | 2014-01-13 | 2022-01-14 | 써멀린 다이어비티즈, 엘엘씨 | 초속효성 인슐린 제형 및 약제학적 전달 시스템 |
| WO2017112952A1 (en) | 2015-12-23 | 2017-06-29 | Case Western Reserve University | Encapsulation of ultra-stable insulin analogues with polymer melts |
-
2018
- 2018-03-07 TW TW107107754A patent/TW201835099A/zh unknown
- 2018-03-07 US US16/492,824 patent/US11174303B2/en active Active
- 2018-03-07 UY UY0001037629A patent/UY37629A/es not_active Application Discontinuation
- 2018-03-07 AR ARP180100528A patent/AR111122A1/es unknown
- 2018-03-07 WO PCT/US2018/021331 patent/WO2018165290A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| US20200140517A1 (en) | 2020-05-07 |
| TW201835099A (zh) | 2018-10-01 |
| US11174303B2 (en) | 2021-11-16 |
| AR111122A1 (es) | 2019-06-05 |
| WO2018165290A1 (en) | 2018-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY37629A (es) | Análogos de insulina de cadena simple estabilizados por un cuarto puente disulfuro | |
| AR109552A1 (es) | Análogos de insulina con afinidad reducida para el receptor de insulina y uso de los mismos | |
| UY37495A (es) | Dinucleótidos cíclicos como agonistas de sting | |
| EA201892737A1 (ru) | ИНЪЕКЦИОННЫЙ РАСТВОР ПРИ pH 7, ВКЛЮЧАЮЩИЙ ПО МЕНЬШЕЙ МЕРЕ ОДИН БАЗАЛЬНЫЙ ИНСУЛИН, pI КОТОРОГО ИМЕЕТ ЗНАЧЕНИЕ ОТ 5,8 ДО 8,5, И СОПОЛИАМИНОКИСЛОТУ, НЕСУЩУЮ КАРБОКСИЛАТНЫЕ ЗАРЯДЫ И ГИДРОФОБНЫЕ РАДИКАЛЫ | |
| UY36870A (es) | Análogos de insulina novedosos | |
| EA201690333A1 (ru) | МОДУЛОКИНЫ НА ОСНОВЕ ДОМЕНА SUSHI IL-15 И IL-15Rα | |
| EA202091160A1 (ru) | Композиции из фрагментов белков шелка и изделия, изготовленные из них | |
| BR112016016290A2 (pt) | Composições farmacêuticas de insulina de ação rápida, conjunto de infusão, sistema de conjunto de infusão e usos de análogos monoméricos ou diméricos de insulina | |
| BR112016024494A8 (pt) | análogo de peptídeo e seu uso | |
| PE20160243A1 (es) | Polipeptido para la escision hidrolitica de la zearalenona y/o derivados de la zearalenona, polinucleotido aislado de la misma y polieptido que contiene aditivo, uso y procedimiento de los mismos | |
| BR112019023445A2 (pt) | Um sistema agrícola | |
| AR102445A1 (es) | COMPOSICIONES Y MÉTODOS RELACIONADOS CON b-GLUCOSIDASA | |
| EA201790842A1 (ru) | Белки cry1da1 с вариантами аминокислотной последовательности, обладающие активностью против чешуекрылых | |
| BR112019014963A8 (pt) | Compostos-bis para dispositivos opticamente ativos | |
| CL2015002914A1 (es) | Tratamiento de la diabetes mellitus mediante formulaciones de la insulinas de acción prolongada | |
| EA201691754A1 (ru) | Рекомбинантный микроорганизм, экспрессирующий аналог авермектина, и его применение | |
| BR112018074094A2 (pt) | plantas transgênicas com aumento da eficiência e do crescimento da fotossíntese | |
| BR112017013453A2 (pt) | novo peptídeo inibidor de pi3ky para o tratamento de doenças do sistema respiratório | |
| EA201591609A1 (ru) | Варианты альфа-амилазы | |
| AR111341A1 (es) | Un conjugado del análogo de insulina con afinidad reducida para el receptor de insulina y uso del mismo | |
| UY37490A (es) | Análogos de insulina de acción rápida de estabilidad mejorada. | |
| BR112015023672A2 (pt) | análogo de insulina, orto-fluoro, sequência de dna codificando a cadeia a de análogo de insulina, sequência de dna codificando a cadeia b de análogo de insulina e uso de um análogo de insulina. | |
| AR102061A1 (es) | Genes de chromobacterium subtsugae | |
| TR201818871T4 (tr) | Lif Üreten Bitkilerde Transgenlerin Geliştirilmiş Seçici Ekspresyonu | |
| CL2020000310A1 (es) | Análogos de insulina acilados novedosos y usos de estos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20231026 |